Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSND.L Regulatory News (SND)

  • There is currently no data for SND

Director's Dealings

19 Jul 2016 07:00

RNS Number : 5579E
Sanderson Group PLC
19 July 2016
 

FOR IMMEDIATE RELEASE 19 JULY 2016

 

SANDERSON GROUP PLC

 

Director's Dealings

 

Sanderson Group plc ('Sanderson'), the software and IT services business specialising in digital retail technology and enterprise software for businesses operating in the manufacturing, wholesale distribution and logistics sectors, announces that it has been informed of the following share dealing by a director.

Mr David Gutteridge, non-executive director, acquired 30,000 ordinary shares at a price of 66.87 pence per ordinary share on 18 July 2016. Following this transaction, Mr Gutteridge has a beneficial interest in 575,000 ordinary shares representing 1.05 per cent of the total issued ordinary share capital of Sanderson.

 

 

Sanderson Group plc 0333 123 1400

Christopher Winn, Chairman

Ian Newcombe, Chief Executive Officer

Adrian Frost, Finance Director

 

Panmure Gordon (UK) Limited 020 7886 2500

Nominated Advisor

Erik Anderson/Fred Walsh

 

Walbrook PR 0117 985 8989

Paul Vann or 07768 807631

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGGUAWMUPQUAB
Date   Source Headline
21st Aug 20247:00 amRNSCancellation - Sondrel (Holdings) plc
12th Aug 20241:54 pmRNSResult of GM, Cancellation and Re-registration
22nd Jul 20247:00 amRNSProposed cancellation of Admission, Notice of GM
18th Jul 20248:09 amRNSFinal Results and Posting of Annual Report-Replace
18th Jul 20247:30 amRNSRestoration - Sondrel (Holdings) plc
18th Jul 20247:01 amRNSChief Financial Officer Succession
18th Jul 20247:00 amRNSFinal Results and Posting of Annual Report
16th Jul 20247:00 amRNSNotice of Results
1st Jul 20247:30 amRNSSuspension - Sondrel (Holdings) plc
27th Jun 20245:32 pmRNSResult of AGM
24th Jun 20244:26 pmRNSSuspension of Trading on AIM
18th Jun 20247:00 amRNSDirectorate Changes
12th Jun 202412:45 pmRNSUpdate re Subscription and Loan Conversion
10th Jun 202410:40 amRNSReceipt of NSIA Approval
30th May 20241:52 pmRNSResult of General Meeting
29th May 20246:07 pmRNSNotice of AGM
29th May 20247:00 amRNSRegulatory Condition to Conditional Subscription
22nd May 20247:00 amRNSChief Executive Officer Succession
14th May 20247:00 amRNSSubscription and Posting of Circular
29th Apr 20242:35 pmRNSPDMR Dealing
29th Apr 20247:00 amRNSSuccessful Milestone Completion
22nd Apr 20244:45 pmRNSPDMR Dealings
10th Apr 20245:26 pmRNSNotification of Major Holdings
2nd Apr 20249:39 amRNSNotification of Major Holdings
28th Mar 20241:08 pmRNSFurther CLN and Amended Exclusivity Agreement
27th Mar 20244:55 pmRNSUpdated Supply Arrangements
25th Mar 20243:46 pmRNSResult of General Meeting
25th Mar 20247:00 amRNSFurther re Material ASIC contract
11th Mar 20247:00 amRNSPosting of Circular and Notice of General Meeting
6th Mar 20247:00 amRNSConvertible Loan Note and Exclusivity Agreement
1st Mar 20247:00 amRNSFurther re Corporate Update
27th Feb 202412:52 pmRNSReplacement: Notification of Major Holdings
27th Feb 20248:33 amRNSNotification of Major Holdings
27th Feb 20247:00 amRNSNew Contract Win and Corporate Update
8th Feb 20248:42 amRNSStatement re Share Price Movement
5th Feb 20247:00 amRNSCorporate Update
10th Jan 20247:00 amRNSFY23 Update
5th Jan 20247:00 amRNSBoard Change
28th Dec 20232:52 pmRNSTrading Update
1st Dec 20233:31 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSResult of placing of shares in Sondrel (Holdings)
23rd Nov 20237:00 amRNSChange of Nominated Adviser and Broker
13th Nov 20237:00 amRNSProduction Order
20th Oct 20237:00 amRNSFounding member of Arm Total Design ecosystem
27th Sep 202312:01 pmRNSNotification of Major Holdings
27th Sep 202311:57 amRNSNotification of Major Holdings
21st Sep 20237:00 amRNSDelivery of prototypes for three ASIC projects
21st Sep 20237:00 amRNSResults for the half year ended 30 June 2023
20th Sep 20231:09 pmRNSBoard Update
18th Sep 20237:00 amRNSSenior Management Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.